Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.
about
Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.Advances in the use of prodrugs for drug delivery to the eye.A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.
P2860
Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Intraocular pharmacokinetics o ...... for cytomegalovirus retinitis.
@en
type
label
Intraocular pharmacokinetics o ...... for cytomegalovirus retinitis.
@en
prefLabel
Intraocular pharmacokinetics o ...... for cytomegalovirus retinitis.
@en
P2093
P2860
P356
P1476
Intraocular pharmacokinetics o ...... for cytomegalovirus retinitis
@en
P2093
Ajay Tammewar
James R Beadle
Lingyun Cheng
William R Freeman
P2860
P304
P356
10.1089/JOP.2010.0155
P577
2011-02-25T00:00:00Z